Aktualisierung der Empfehlungen der AG Mammadiagnostik der Deutschen Röntgengesellschaft zur Durchführung der Mamma-MRT

Kernaussagen

• Die Mamma-MRT ist ein wesentlicher Bestandteil der Mammadiagnostik.

• Die Empfehlungen zur Durchführung der Mamma-MRT wurden aktualisiert.

• Anhand der Empfehlungen kann indikationsangepasst die Mamma-MRT durchgeführt werden.

• Eine Tabelle liefert eine kompakte und schnelle Übersicht. Ausführlichere Kommentare ergänzen die Tabelle.

• Anhand der Empfehlungen kann die „klassische“ Mamma-MRT durchgeführt werden. Tipps für spezielle Fragestellungen, wie zum Beispiel Implantatruptur, Milchgangspathologie oder lokaler Lymphknotenstatus, sind enthalten.

Zitierweise

• Wenkel E, Wunderlich P, Fallenberg E et al. Recommendations of the German Radiological Society’s breast imaging working group regarding breast MRI. Fortschr Röntgenstr 2024; 196: 939 – 944

Keywords

breast - MR-diffusion/perfusion - MR-imaging - imaging sequences

Publication History

Received: 06 April 2023

Accepted: 15 November 2023

Article published online:
18 January 2024

• References

• 1 Updated Recommendations for MRI of the Breast. Fortschr Röntgenstr 2014; 186: 482-483
• 2 Morris EA, Comstock CE, Lee CH. et al. ACR BI-RADS Magnetic Resonance Imaging. In: ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA: 2013
• 3 European Society of Urogenital Radiology. ESUR Guidelines on Contrast Agents 10.0. 2018
• 4 Maijers MC, Niessen FB, Veldhuizen JFH. et al. MRI screening for silicone breast implant rupture: accuracy, inter- and intraobserver variability using explantation results as reference standard. Eur. Radiol 2014; 24: 1167-1175
• 5 Thomassin-Naggara I, Trop I, Lalonde L. et al. Tips and techniques in breast MRI. Diagn. Interv. Imaging 2012; 93: 828-839
• 6 Wenkel E, Janka R, Uder M. et al. Does direct MR galactography have the potential to become an alternative diagnostic tool in patients with pathological nipple discharge?. Clin. Imaging 2011; 35: 85-93
• 7 Baltzer P, Mann RM. On behalf of the EUSOBI international Breast Diffusion-Weighted Imaging working group. et al. Diffusion-weighted imaging of the breast – a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur. Radiol 2020; 30: 1436-1450
• 8 Janka R, Hammon M, Geppert C. et al. Weighted MR Imaging of Benign and Malignant Breast Lesions Before and After Contrast Enhancement. RöFo - Fortschritte Auf Dem Geb. Röntgenstrahlen Bildgeb. Verfahr 2013; 186: 130-135
• 9 Clauser P, Krug B, Bickel H. et al. Diffusion-weighted Imaging Allows for Downgrading MR BI-RADS 4 Lesions in Contrast-enhanced MRI of the Breast to Avoid Unnecessary Biopsy. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res 2021; 27: 1941-1948
• 10 Rahbar H, Zhang Z, Chenevert TL. et al. Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702). Clin. Cancer Res 2019; 25: 1756-1765
• 11 Stucky C-CH, McLaughlin SA, Dueck AC. et al. Does magnetic resonance imaging accurately predict residual disease in breast cancer?. Am. J. Surg 2009; 198: 547-552
• 12 Chae EY, Cha JH, Kim HH. et al. Evaluation of Residual Disease Using Breast MRI After Excisional Biopsy for Breast Cancer. Am. J. Roentgenol 2013; 200: 1167-1173
• 13 Updated Recommendations for MRI of the Breast. RöFo – Fortschritte Auf Dem Geb. Röntgenstrahlen Bildgeb. Verfahr 2014; 186: 482-483
• 14 Hansen NL, Kuhl CK, Barabasch A. et al. Does MRI Breast “Density” (Degree of Background Enhancement) Correlate With Mammographic Breast Density?: MRI Breast Enhancement and Mammographic Density. J. Magn. Reson. Imaging 2014; 40: 483-489
• 15 King V, Gu Y, Kaplan JB. et al. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur. Radiol 2012; 22: 2641-2647
• 16 Kuhl CK, Bieling HB, Gieseke J. et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997; 203: 137-144
• 17 Baltzer P, Dietzel M, Vag T. et al. Clinical MR Mammography: Impact of Hormonal Status on Background Enhancement and Diagnostic Accuracy. RöFo – Fortschritte Auf Dem Geb. Röntgenstrahlen Bildgeb. Verfahr 2011; 183: 441-447
• 18 Müller-Schimpfle M, Ohmenhaüser K, Stoll P. et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 1997; 203: 145-149
• 19 Scaranelo AM, Carrillo MC, Fleming R. et al. Pilot Study of Quantitative Analysis of Background Enhancement on Breast MR Images: Association with Menstrual Cycle and Mammographic Breast Density. Radiology 2013; 267: 692-700
• 20 Hambly NM, Liberman L, Dershaw DD. et al. Background Parenchymal Enhancement on Baseline Screening Breast MRI: Impact on Biopsy Rate and Short-Interval Follow-Up. Am. J. Roentgenol 2011; 196: 218-224
• 21 DeMartini WB, Liu F, Peacock S. et al. Background Parenchymal Enhancement on Breast MRI: Impact on Diagnostic Performance. Am. J. Roentgenol 2012; 198: W373-W380
• 22 Ray KM, Kerlikowske K, Lobach IV. et al. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices. Radiology 2018; 286: 822-829
• 23 Dontchos BN, Rahbar H, Partridge SC. et al. Influence of Menstrual Cycle Timing on Screening Breast MRI Background Parenchymal Enhancement and Diagnostic Performance in Premenopausal Women. J. Breast Imaging 2019; 1: 205-211
• 24 Lee CH, Bryce Y, Zheng J. et al. Outcome of Screening MRI in Premenopausal Women as a Function of the Week of the Menstrual Cycle. Am. J. Roentgenol 2020; 214: 1175-1181
• 25 Schrading S, Schild H, Kühr M. et al. Effects of Tamoxifen and Aromatase Inhibitors on Breast Tissue Enhancement in Dynamic Contrast – enhanced Breast MR Imaging: A Longitudinal Intraindividual Cohort Study. Radiology 2014; 271: 45-55
• 26 King V, Kaplan J, Pike MC. et al. Impact of Tamoxifen on Amount of Fibroglandular Tissue, Background Parenchymal Enhancement, and Cysts on Breast Magnetic Resonance Imaging: Tamoxifen and Breast Tissue Features on MRI. Breast J 2012; 18: 527-534
• 27 King V, Goldfarb SB, Brooks JD. et al. Effect of Aromatase Inhibitors on Background Parenchymal Enhancement and Amount of Fibroglandular Tissue at Breast MR Imaging. Radiology 2012; 264: 670-678
• 28 Taron J, Fleischer S, Preibsch H. et al. Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?. Eur. Radiol 2019; 29: 1187-1193
• 29 Fischer U, Korthauer A, Baum F. et al. Short first-pass MRI of the breast. Acta Radiol 2012; 53: 267-269
• 30 Kuhl CK, Schrading S, Strobel K. et al. Abbreviated Breast Magnetic Resonance Imaging (MRI): First Postcontrast Subtracted Images and Maximum-Intensity Projection – A Novel Approach to Breast Cancer Screening With MRI. J. Clin. Oncol 2014; 32: 2304-2310
• 31 Grimm LJ, Soo MS, Yoon S. et al. Abbreviated Screening Protocol for Breast MRI. Acad. Radiol 2015; 22: 1157-1162
• 32 Moschetta M, Telegrafo M, Rella L. et al. Abbreviated Combined MR Protocol: A New Faster Strategy for Characterizing Breast Lesions. Clin. Breast Cancer 2016; 16: 207-211
• 33 Chen S-Q, Huang M, Shen Y-Y. et al. Abbreviated MRI Protocols for Detecting Breast Cancer in Women with Dense Breasts. Korean J. Radiol 2017; 18: 470
• 34 Heacock L, Melsaether AN, Heller SL. et al. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity. Eur. J. Radiol 2016; 85: 815-823
• 35 Mann RM, Mus RD, van Zelst J. et al. A Novel Approach to Contrast-Enhanced Breast Magnetic Resonance Imaging for Screening: High-Resolution Ultrafast Dynamic Imaging. Invest. Radiol 2014; 49: 579-585
• 36 Kim ES, Cho N, Kim S-Y. et al. Added value of ultrafast sequence in abbreviated breast MRI surveillance in women with a personal history of breast cancer: A multireader study. Eur. J. Radiol 2022; 151: 110322
• 37 Baxter GC, Selamoglu A, Mackay JW. et al. A meta-analysis comparing the diagnostic performance of abbreviated MRI and a full diagnostic protocol in breast cancer. Clin. Radiol 2021; 76: 154.e23-154.e32
• 38 Geach R, Jones LI, Harding SA. et al. The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis. Clin. Radiol 2021; 76: 154.e11-154.e22
• 39 Mango VL, Morris EA, David Dershaw D. et al. Abbreviated protocol for breast MRI: Are multiple sequences needed for cancer detection?. Eur. J. Radiol 2015; 84: 65-70
• 40 Mariscotti G, Houssami N, Durando M. et al. Digital Breast Tomosynthesis (DBT) to Characterize MRI-Detected Additional Lesions Unidentified at Targeted Ultrasound in Newly Diagnosed Breast Cancer Patients. Eur. Radiol 2015; 25: 2673-2681
• 41 Clauser P, Carbonaro LA, Pancot M. et al. Additional findings at preoperative breast MRI: the value of second-look digital breast tomosynthesis. Eur. Radiol 2015; 25: 2830-2839
• 42 Nida BA, Rooney TB, Miller MM. Utility of MRI-Directed Contrast-Enhanced Mammography for Biopsy Planning for Suspicious MRI-Detected Breast Lesions. AJR Am J Roentgenol 2023; 220 (02) 202-211
• 43 Alcantara R, Posso M, Pitarch M. et al. Contrast-enhanced mammography-guided biopsy: technical feasibility and first outcomes. Eur. Radiol 2023; 33: 417-428
• 44 Spick C, Baltzer PAT. Diagnostic Utility of Second-Look US for Breast Lesions Identified at MR Imaging: Systematic Review and Meta-Analysis. Radiology 2014; 273: 401-409
• 45 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms. 2021
• 46 Huang ML, Speer M, Dogan BE. et al. Imaging-Concordant Benign MRI-Guided Vacuum-Assisted Breast Biopsy May Not Warrant MRI Follow-Up. Am. J. Roentgenol 2017; 208: 916-922
• 47 Lambert J, Steelandt T, Heywang-Köbrunner SH. et al. Long-term MRI-guided vacuum-assisted breast biopsy results of 600 single-center procedures. Eur. Radiol 2021; 31: 4886-4897